These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
5. [Undesirable adverse effects of the antirheumatic pharmacotherapy on the eyes]. Verraz R. Arch Sci Med (Torino); 1974 May; 131(3):167-72. PubMed ID: 4463933 [No Abstract] [Full Text] [Related]
6. Ocular accumulation and toxicity of certain systemically administered drugs. Mason CG. J Toxicol Environ Health; 1977 May; 2(5):977-95. PubMed ID: 405503 [Abstract] [Full Text] [Related]
7. [Tolerance of long-term indomethacin treatment]. Bröll H, Eberl R, Sochor H, Tausch G. Wien Klin Wochenschr; 1972 Jun 30; 84(26):421-4. PubMed ID: 4625681 [No Abstract] [Full Text] [Related]
8. Drugs affecting the eye. Taylor F. Aust Fam Physician; 1985 Aug 30; 14(8):744-5. PubMed ID: 2864912 [Abstract] [Full Text] [Related]
14. [Indomethacin in rheumatic diseases with special reference to ophthalmologic studies]. Klein G, Fellner S, Fellner R. Med Klin; 1972 Feb 25; 67(8):250-4. PubMed ID: 4555586 [No Abstract] [Full Text] [Related]
15. [Long term treatment of rheumatoid arthritis. Experiences with D-penicillamine in comparison with gold and immunosuppressive drugs (author's transl)]. Warnatz H, Scheiffarth F, Gutmann W. Med Klin; 1975 Sep 19; 70(38):1509-15. PubMed ID: 810648 [Abstract] [Full Text] [Related]